Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adherence to antihypertensive drug treatment in Argentina: A multicenter study.
Espeche W, Salazar MR, Sabio R, Diaz A, Leiva Sisnieguez C, Olano D, Balbin E, Renna N, Grosse P, Flores RA, Lagos AC, Ferrer P, Poppe S, Risso Patron F, Sotnieczuk Stasiuk VD, Valentini E, Cardozo JR, Romano JR, Parodi R, Carbajal H. Espeche W, et al. Among authors: leiva sisnieguez c. J Clin Hypertens (Greenwich). 2020 Apr;22(4):656-662. doi: 10.1111/jch.13830. Epub 2020 Feb 17. J Clin Hypertens (Greenwich). 2020. PMID: 32065507 Free PMC article.
Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM. Salazar MR, et al. Among authors: leiva sisnieguez ce. J Intern Med. 2013 Jun;273(6):595-601. doi: 10.1111/joim.12036. Epub 2013 Feb 18. J Intern Med. 2013. PMID: 23331522 Free article.
Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects.
Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, Leiva Sisnieguez BC, March CE, Stavile RN, Balbín E, Reaven GM. Salazar MR, et al. Among authors: leiva sisnieguez bc, leiva sisnieguez ce. J Am Soc Hypertens. 2014 Oct;8(10):724-31. doi: 10.1016/j.jash.2014.08.002. Epub 2014 Aug 14. J Am Soc Hypertens. 2014. PMID: 25418494
Insulin resistance: The linchpin between prediabetes and cardiovascular disease.
Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, March CE, Reaven GM. Salazar MR, et al. Among authors: leiva sisnieguez bc, leiva sisnieguez ce. Diab Vasc Dis Res. 2016 Mar;13(2):157-63. doi: 10.1177/1479164115610057. Epub 2016 Jan 22. Diab Vasc Dis Res. 2016. PMID: 26802220 Free article.
Use of the triglyceride/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity?
Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Marillet AG, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, March CE, Reaven GM. Salazar MR, et al. Among authors: leiva sisnieguez bc, leiva sisnieguez ce. J Investig Med. 2017 Feb;65(2):323-327. doi: 10.1136/jim-2016-000248. Epub 2016 Sep 16. J Investig Med. 2017. PMID: 27638846
Nocturnal but not Diurnal Hypertension Is Associated to Insulin Resistance Markers in Subjects With Normal or Mildly Elevated Office Blood Pressure.
Salazar MR, Espeche WG, Stavile RN, Disalvo L, Tournier A, Leiva Sisnieguez BC, Varea A, Leiva Sisnieguez CE, March CE, Carbajal HA. Salazar MR, et al. Among authors: leiva sisnieguez bc, leiva sisnieguez ce. Am J Hypertens. 2017 Oct 1;30(10):1032-1038. doi: 10.1093/ajh/hpx096. Am J Hypertens. 2017. PMID: 28586418
Could self-measured office blood pressure be a hypertension screening tool for limited-resources settings?
Salazar MR, Espeche WG, Stavile RN, Balbín E, Leiva Sisnieguez BC, Leiva Sisnieguez CE, March CE, Cor S, Eugenio Acero I, Carbajal HA. Salazar MR, et al. Among authors: leiva sisnieguez bc, leiva sisnieguez ce. J Hum Hypertens. 2018 Jun;32(6):415-422. doi: 10.1038/s41371-018-0057-y. Epub 2018 May 1. J Hum Hypertens. 2018. PMID: 29713048 Clinical Trial.
20 results